Biotechnology Stocks I Performance Guide: Rhythm Pharmaceuticals, Inc. (RYTM)
RYTM has no dividends.
Table and Chart of RYTM Performance
See what a $1,000 investment in RYTM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RYTM Returns | |
|---|---|
| Start Date | Nov-30-2017 |
| Start Price | $28.58 |
| End Date | May-10-2024 |
| End Price | $39.14 |
| # Prices | 79 |
| Min Date | May-31-2022 |
| Min Price | $3.44 |
| Max Date | Dec-29-2023 |
| Max Price | $45.97 |
| Total Return | 36.95% |
| Annualized Return | 4.89% |
| Current Value of $1,000 Purchase | $1,369 |
| Number Returns | 3,081 |
| Average Return | 19.78% |
| Number Profitable Returns | 1,319 |
| Percent Profitable Returns | 42.81% |
| Number Unprofitable Returns | 1,762 |
| Percent Unprofitable Returns | 57.19% |
| Profitable to Unprofitable Returns Ratio | 0.75 |
| RYTM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,386,479,000 |
| Beta | 1.935 | Price to Sales | 31.33 |
| Earnings per Share | $-4.6300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 14.29 |
| PRICE DATA | |
| 52 Week High | $52.57 |
| 52 Week Low | $15.5 |
| Analyst Target Price | $57.22 |
| 50-Day Moving Average | $40.5 |
| 200-Day Moving Average | $34.96 |
| FINANCIAL DATA | |
| Revenue per Share | $1.571 |
| Revenue | $91,926,000 |
| Profit Margin | -297.9% |
| Return on Equity | -194.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RYTM Compare Returns with S&P 500
RYTM Trendline Chart
RYTM Moving Average Chart
RYTM Stock Return Map - See Patterns of Gains and Losses
RYTM Stock Returns/Purchase Dates